Comparing aromatase inhibitor therapy with tamoxifen in postmenopausal women with estrogen receptor-positive early breast cancer, it was demonstrated a superior efficacy for AIs treatment; this is quickly becoming the gold standard method. The gene discussed is ESR1; the disease is breast cancer.